
"As a result, the CSP's position is that there are now no appropriate circumstances where physiotherapists should be preparing, injecting, or utilising PRP therapy with patients, and therefore, effective immediately, all physiotherapists should stop utilising PRP with their patients. " 08 JUNE 2023 - 11:11AM[2]
Platelet-rich plasma (PRP) injections have gained popularity in recent years as a potential treatment for musculoskeletal conditions. However, a recent decision by the Chartered Society of Physiotherapy (CSP) has brought attention to the legal and regulatory status of this therapy. I will explore the concept of unlicensed medicine, delve into the reasons behind the CSP's decision, and shed light on the implications for physiotherapists and patients.
Unlicensed Medicine: What Does It Mean?
Imagine a world where any substance, regardless of its safety and efficacy, could be administered as a medical treatment. Sounds risky, right? That's where the concept of unlicensed medicine comes into play. Unlicensed medicine refers to medicinal products that have not undergone the rigorous process of obtaining a marketing authorization and manufacturing license. Essentially, these products lack the necessary scientific evidence to support their use and ensure patient safety.
PRP and its Legal Classification
The CSP's recent decision to halt the provision of PRP therapy by physiotherapists stems from the classification of PRP as a medicinal product. The Medicines and Healthcare Products Regulatory Agency (MHRA), the regulatory body responsible for overseeing medicines in the UK, has determined that PRP falls under the purview of Human Medicines Legislation (HMR).
So, what does that mean? Well, according to the HMR, any product claiming to restore, correct, or modify physiological functions through pharmacological, immunological, or metabolic actions is considered a medicinal product. In the case of PRP, physiotherapists use it with the intention of reducing pain and promoting healing, which the MHRA considers to be medicinal claims. As a result, physiotherapists must adhere to the same regulatory standards as other healthcare professionals who administer medicinal products.
Implications for Physiotherapists and Patients
The CSP's stance on PRP is clear: physiotherapists must immediately cease providing this therapy due to its classification as an unlicensed human medicine. This decision prioritizes patient safety and emphasizes the importance of adhering to legal and regulatory frameworks in healthcare.
While doctors still have the option to prepare and use PRP under specific exemptions, physiotherapists do not possess the necessary authorizations and licenses to do so. The exemption that allows certain healthcare professionals to use unlicensed medicines does not extend to physiotherapists. Consequently, they are unable to legally provide PRP therapy.
Moving Forward: Patient Care and Legal Compliance
The CSP advises physiotherapists to discontinue PRP treatment and inform their patients about this change. Ensuring patient well-being is of utmost importance, and physiotherapists are encouraged to provide patients with a list of alternative healthcare professionals who are authorized to administer PRP therapy. This ensures that patients can continue their treatment journey with minimal disruption.
Insurance Coverage and the Legal Landscape
It's important to note that this issue goes beyond insurance coverage. Even if physiotherapists possess insurance from other providers, the use of PRP as a treatment modality is no longer legally acceptable. Insurance companies, including James Hallam, have acknowledged this change in legal status. They will honor past liabilities but exclude events from June 8th, 2023, as physiotherapists must comply with the updated regulations.
The CSP's decision to halt PRP therapy highlights the need for proper scrutiny, research, and authorization of medical interventions. Platelet-rich plasma injections have shown promise, but their legal classification as an unlicensed human medicine underscores the importance of prioritizing patient safety. Physiotherapists must respect these guidelines and explore alternative treatment options within the boundaries of the law. By staying informed about evolving regulations and prioritizing patient well-being, healthcare professionals can continue to provide effective care while upholding legal and ethical standards.
Other Countries
Please let me know in the comments what it looks like in your country. Can you do PRP injections as a physiotherapist? According to my findings, in the United States, the regulations regarding physiotherapists administering PRP injections can vary from state to state. While I don't have an exhaustive list of specific states where physiotherapists are authorized to administer PRP injections, I can provide examples of states where this practice may be allowed or where there have been discussions and developments on the topic:
Arizona: In Arizona, physiotherapists may have been granted the authority to administer PRP injections under specific circumstances. The Arizona Board of Physical Therapy has established guidelines and requirements that physiotherapists must meet to perform this procedure. ( Please confirm if you know)
New Mexico: Physiotherapists in New Mexico may have the authorization to administer PRP injections within their scope of practice. However, it is important for physiotherapists to comply with the regulations and guidelines set forth by the New Mexico Physical Therapy Board.
I couldn't find any other places Physiotherapists could inject PRP. I love to see your comments.
References and more info
Comments